Connor, Clark & Lunn Investment Management Ltd.

Position in ORMP — Oramed Pharmaceuticals Inc.

CIK 1596800 VANCOUVER, A1

Position in ORMP

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$170,703

+$46,059 QoQ

Shares Held

50,207

+14.8% QoQ

Ownership

0.123%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. ORMP ranks #91 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	251,711	$112,399,029
2	IONS	Ionis Pharmaceuticals Inc	874,089	$65,635,343
3	ARWR	Arrowhead Pharmaceuticals, Inc.	836,981	$52,478,708
4	MIRM	Mirum Pharmaceuticals, Inc.	479,476	$44,293,992
5	REGN	Regeneron Pharmaceuticals, Inc.	32,164	$24,851,192
6	AXSM	Axsome Therapeutics, Inc.	134,792	$22,782,543
7	SRPT	Sarepta Therapeutics, Inc.	1,019,951	$22,194,133
8	TERN	Terns Pharmaceuticals, Inc.	384,681	$20,280,382

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$170,703	50,207	+14.8%	Shares	Sole	2026-05-11
2025-12-31	$124,644	43,735	+54.9%	Shares	Sole	2026-02-10
2025-09-30	$74,561	28,243	-53.3%	Shares	Sole	2025-11-13
2025-06-30	$136,010	60,449	-30.6%	Shares	Sole	2025-08-07
2025-03-31	$186,471	87,136	-18.6%	Shares	Sole	2025-05-12
2024-12-31	$259,090	107,062	-4.0%	Shares	Sole	2025-02-10
2024-09-30	$272,106	111,519	+119.6%	Shares	Sole	2024-11-08
2021-12-31	$725,224	50,786	+96.4%	Shares	Sole	2022-02-10
2021-09-30	$568,270	25,854	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.